Hypoglycemic Effect and Mechanism of Chinese Medicine Saponins： A Review

PENG Chuan; HU Xuefang; CHEN Zhengtao; DOU Chenyu; YANG Peng; BI Jingxin; DING Lei; WU Lili; QIN Lingling; LIU Tonghua

doi:10.13422/j.cnki.syfjx.20222102

您当前的位置：

首页 >

文章列表页 >

Hypoglycemic Effect and Mechanism of Chinese Medicine Saponins： A Review

更新时间：2023-04-28

- Hypoglycemic Effect and Mechanism of Chinese Medicine Saponins： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 11, Pages: 266-275(2023)
- 作者机构：
  
  1.成都中医药大学临床医学院，成都 610036
  2.北京中医药大学中医养生研究所，北京 100029
  3.陕西中医药大学第一临床医学院，西安 711301
  4.北京中医药大学第二临床医学院，北京 100078
  5.北京中医药大学，北京 100029
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20222102
  CLC： R2-0;R22;R285.5;R284;R33
- Published：05 June 2023，
  
  Published Online：17 November 2022，
  
  Received：19 August 2022，
- 稿件说明：
扫描看全文
彭川,胡学芳,陈正涛等.中药皂苷类成分的降糖作用及机制研究进展[J].中国实验方剂学杂志,2023,29(11):266-275.

PENG Chuan,HU Xuefang,CHEN Zhengtao,et al.Hypoglycemic Effect and Mechanism of Chinese Medicine Saponins： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):266-275.
彭川,胡学芳,陈正涛等.中药皂苷类成分的降糖作用及机制研究进展[J].中国实验方剂学杂志,2023,29(11):266-275. DOI： 10.13422/j.cnki.syfjx.20222102.

PENG Chuan,HU Xuefang,CHEN Zhengtao,et al.Hypoglycemic Effect and Mechanism of Chinese Medicine Saponins： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(11):266-275. DOI： 10.13422/j.cnki.syfjx.20222102.

摘要

2型糖尿病（T2DM）是一种以胰岛素抵抗、高胰岛素血症、糖脂代谢紊乱为特征，临床以血糖升高为主要表现的慢性代谢性系统疾病。其病因及发病机制复杂，目前尚无完全治愈的手段，严重威胁着人类的健康，给社会和家庭带来了沉重的负担。皂苷是一类结构比较复杂的苷类化合物，具有来源广、安全性高、不良反应低等优点。中药皂苷作为中药重要的活性成分，具有降血糖、降血脂、抗炎、抗氧化、抗肿瘤、调节免疫等多种生物活性。近年来，众多研究表明中药皂苷类成分可有效地防治糖尿病。虽然中药皂苷类成分降糖作用及机制研究众多，但目前尚缺乏对中药皂苷类成分治疗T2DM作用及机制研究的系统综述。故该文围绕中药皂苷类成分改善胰岛

细胞功能、改善胰岛素抵抗、抑制糖苷酶活性、降低炎症反应、抗氧化应激、调节肠道菌群等降糖机制进行系统归纳，并分析目前研究存在的问题及发展趋势，以期为深入研究中药皂苷类成分的降糖作用提供理论基础，为药物的开发与临床应用提供科学依据。

Abstract

Type 2 diabetes mellitus （T2DM） is a chronic metabolic disease characterized by insulin resistance， hyperinsulinemia， and disturbance of glucose and lipid metabolism， with elevated blood glucose as the main clinical manifestation. Due to its complex etiology and pathogenesis， there is no effective treatment， which critically threatens human health and places a heavy burden on society and families. Saponins are a class of glycosides with complex structures that have the advantage of a wide range of sources， elevated safety， and low adverse effects. As an essential active ingredient in Chinese medicine， Chinese medicine saponins have a variety of biological activities such as hypoglycemia， hypoglycaemia， anti-inflammation， antioxidation， anti-tumor， and immune modulation. In recent years， numerous studies have shown that Chinese medicine saponins are effective in preventing and treating T2DM. Although there have been numerous studies on the hypoglycemic effects and mechanisms of Chinese medicine saponins， there has been no systematic review of the mechanisms of Chinese medicine saponins in the treatment of T2DM. Therefore， to provide a theoretical basis for an in-depth study of the hypoglycemic effects of Chinese medicine saponins and a scientific basis for the development and clinical application of drugs， this paper systematically summarized the hypoglycemic mechanisms of Chinese medicine saponins， such as improving islet

-cell function， improving insulin resistance， inhibiting glycosidase activity， reducing the inflammatory response， anti-oxidative stress， and regulating intestinal flora， and analyzed the current research problems and development trends.

关键词

中药皂苷类成分2型糖尿病作用机制研究进展

Keywords

Chinese medicine saponinstype 2 diabetes mellitusmechanismresearch progress

references

SAJAN M P，LEE M C，FOUFELLE F，et al.Coordinated regulation of hepatic FoxO1，PGC-1α and SREBP-1c facilitates insulin action and resistance［J］.Cell Signal，2018，43：62-70.

OGURTSOVA K，GUARIGUATA L，BARENGO N，et al. IDF diabetes atlas： Global estimates of undiagnosed diabetes in adults for 2021［J］.Diabetes Res and Clin Pract，183（6）：109118-109140.

姜广坤，牛雯颖，张文娓，等.连梅汤对糖尿病模型小鼠血糖和肠道菌群的影响［J］.世界科学技术—中医药现代化，2022，5：1953-1961.

KHEIRANDISH M，MAHBOOBI H，YAZDANPARAST M，et al.Challenges related to glycemic control in type 2 diabetes mellitus patients［J］.Curr Drug Metab，2017，18（2）：157-162.

SUN H X，XIE Y，YE Y P.Advances in saponin-based adjuvants［J］.Vaccine，2009，27（12）：1787-1796.

ZHOU P，XIE W，HE S，et al.Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis［J］.Cells，2019，8（3）：204.

YIN M，ZHANG J，WANG L，et al.Ten new dammarane-type saponins with hypolipidemia activity from a functional herbal tea-gynostemma pentaphyllum［J］.Molecules，2020，25（16）：3737.

KRENTZ N A J，GLOYN A L.Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics［J］.Nat Rev Endocrinol，2020，16（4）：202-212.

KIM S S，JANG H J，OH M Y，et al.Ginsenoside Rg3 enhances islet cell function and attenuates apoptosis in mouse islets［J］.Transplant Proc，2014，46（4）：1150-1155.

DONG Z，XU M，HUANG J，et al.The protective effect of Ginsenoside Rg1 on aging mouse pancreas damage induced by D-galactose［J］.Exp Ther Med，2017，14（1）：616-622.

YU W，WANG Y，JIANG D，et al.A saponin from astragalus promotes pancreatic ductal organoids differentiation into insulin-producing cells［J］.Phytomedicine，2022，102（7）：154-162.

KALAILINGAM P，KANNAIAN B，TAMILMANI E，et al .Efficacy of natural diosgenin on cardiovascular risk，insulin secretion，and beta cells in streptozotocin （STZ）-induced diabetic rats［J］.Phytomedicine，2014，21（10）：1154-1161.

钟艳梅，陈坚平，钟静君，等.知母总皂苷对INS-1胰岛β细胞功能的影响［J］.中华中医药杂志，2018，33（6）：2631-2633.

KELLER A C，MA J，KAVALIER A，et al.Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro［J］.Phytomedicine，2011，19（1）：32-37.

CHEN X，WEI R，JIN T，et al.Notoginsenoside R1 alleviates TNF-α-induced pancreatic β-cell Min6 apoptosis and dysfunction through up-regulation of miR-29a［J］.Artif Cells Nanomed Biotechnol，2019，47（1）：2379-2388.

崔佳，段佳林，王磊，等.竹节参皂苷Ⅳa通过Akt/mTOR通路保护胰岛β细胞损伤［J］.现代生物医学进展，2018，18（17）：3224-3229.

张翕宇，邢亦谦，何雨池，等.基于NLRP3/GSDMD信号通路研究人参皂苷Rb1对高糖诱导的胰岛β细胞焦亡的影响［J］.中国医院药学杂志，2022，42（17）：1766-1770.

PETERSEN M C，SHULMAN G I.Mechanisms of insulin action and insulin resistance［J］.Physiol Rev，2018，98（4）：2133-2223.

LI H，YU L，ZHAO C，et al.Dioscin attenuates high-fat diet-induced insulin resistance of adipose tissue through the IRS-1/PI3K/Akt signaling pathway［J］.Mol Med Rep，2019，19（2）：1230-1237.

WANG Q，WU X，SHI F，et al.Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L.in STZ-induced type 2 diabetic mice［J］.Biomed Pharmacother，2019，109：744-750.

徐杰，董金香，王蓓，等.人参皂苷Rg3治疗肥胖诱导的2型糖尿病研究进展［J］.中华中医药学刊，2021，39（7）：102-106.

LEE O H，LEE H H，KIM J H，et al.Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes［J］.Phytother Res，2011，25（5）：768-773.

DAI S，HONG Y，XU J，et al.Ginsenoside Rb2 promotes glucose metabolism and attenuates fat accumulation via Akt-dependent mechanisms［J］.Biomed Pharmacother，2018，100（4）：93-100.

魏桂梅，任锟，赵璐，等.薯蓣皂苷通过调控SIRT1-FoxO1-自噬通路减轻糖尿病大鼠胰岛素抵抗［J］.中国病理生理杂志，2022，38（2）：303-310.

BEHL T，GUPTA A，SEHGAL A，et al.Exploring protein tyrosine phosphatases （PTP） and PTP-1B inhibitors in management of diabetes mellitus［J］.Biomed Pharmacother，2022，153（2）：113405-113452.

ZHOU X，WANG L L，TANG W J，et al.Astragaloside Ⅳ inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin-resistant HepG2 cells and triglyceride accumulation in oleic acid （OA）-treated HepG2 cells［J］.Ethnopharmacol，2021，268（7）：113556-113562.

KLOMANN S D，MUELLER A S，PALLAUF J，et al.Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice［J］.Br J Nutr，2010，104（11）：1613-20.

HUANG X，LIU G，GUO J，et al.The PI3K/Akt pathway in obesity and type 2 diabetes［J］.Int J Biol Sci，2018，14（11）：1483-1496.

LETO D，SALTIEL A R.Regulation of glucose transport by insulin： Traffic control of GLUT4［J］.Nat Rev Mol Cell Biol，2012，13（6）：383-396.

SEO Y H，JUNG H J，SHIN H T，et al.Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation［J］.Aging Cell，2008，7（6）：894-907.

WU F，SHAO Q，XIA Q，et al.A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway［J］.Phytomedicine，2021，83（9）：153487-153495.

XU J，WANG S，FENG T，et al.Hypoglycemic and hypolipidemic effects of total saponins from Stauntonia chinensis in diabetic db/db mice［J］.J Cell Mol Med，2018，22（12）：6026-6038.

LIU Z，QU C Y，LI J X，et al.Hypoglycemic and hypolipidemic effects of malonyl ginsenosides from american ginseng （Panax quinquefolius L.） on type 2 diabetic mice［J］.ACS Omega，2021，6（49）：33652-33664.

FENG M，LIU F，XING J，et al.Anemarrhena saponins attenuate insulin resistance in rats with high-fat diet-induced obesity via the IRS-1/PI3K/Akt pathway［J］.J Ethnopharmacol，2021，277（2）：114251-114263.

WEI Y，YANG H，ZHU C，et al.Ginsenoside Rg5 relieves type 2 diabetes by improving hepatic insulin resistance in db/db mice［J］.J Funct Foods，2020，71（6）：104014-104026.

季天娇，王中元，朱云峰，等.黄芪甲苷调节PI3K/Akt/FoxO1通路抑制糖尿病大鼠肝糖异生［J］.中国实验方剂学杂志，2020，26（1）：78-86.

李梦洋，常远，冯国军，等.α-淀粉酶抑制剂构效关系及应用研究进展［J］.食品工业科技，2022，43（12）：475-485.

TAN K，TESAR C，WILTON R，et al.Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase.［J］.Protein Sci，2018，27（8）：1498-1508.

LUO J，CHAI Y，ZHAO M，et al.Hypoglycemic effects and modulation of gut microbiota of diabetic mice by saponin from Polygonatum sibiricum［J］.Food Funct，2020，11（5）：4327-4338.

SRINUANCHAI W，NOOIN R，PITCHAKARN P，et al.Inhibitory effects of Gymnema inodorum （Lour.） Decne leaf extracts and its triterpene saponin on carbohydrate digestion and intestinal glucose absorption［J］.J Ethnopharmacol，2021，266（10）：1133-1145.

LI C，DENG S，LIU W，et al.α-Glucosidase inhibitory and anti-inflammatory activities of dammarane triterpenoids from the leaves of Cyclocarya paliurus［J］.Bioorg Chem，2021，111（5）：104847-104857.

ZHANG H，XU J，WANG M，et al.Steroidal saponins and sapogenins from fenugreek and their inhibitory activity against α-glucosidase［J］.Steroids，2020，161（10）：108690-108702.

韩君，郑钦方，方良子，等.白扁豆总皂苷降糖活性组分筛选及其功能评价［J］.数字中医药：英文版，2021，4（3）：229-240.

LEE J S，CHOI M S，SEO K I，et al.Platycodi radix saponin inhibits α-glucosidase in vitro and modulates hepatic glucose-regulating enzyme activities in C57BL/KsJ-db/db mice［J］.Arch Pharm Res，2014，37（6）：773-782.

黄盼玲，肖颖梅，李泊村，等.罗汉果皂苷改善糖尿病小鼠血糖的作用研究［J］.食品研究与开发，2022，43（5）：8-13.

GHOSH S，MORE P，DERLE A，et al.Diosgenin from Dioscorea bulbifera： Novel hit for treatment of type Ⅱ diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase［J］.PLoS One，2014，9（9）：e106039.

DONATH M Y，SHOELSON S E.Type 2 diabetes as an inflammatory disease［J］.Nat Rev Immunol，2011，11（2）：98-107.

SHI K，ZHU J，CHEN D，et al.Lipidomics analysis of timosaponin BⅡ in INS-1 cells induced by glycolipid toxicity and its relationship with inflammation［J］.Chem Biodivers，2020，17（4）：e1900684-e1900695.

王红菊.山茱萸总皂苷提取工艺及改善糖尿病相关机制研究［D］.西安：陕西师范大学，2015.

ZHU Y，SU Y，ZHANG J，et al.Astragaloside Ⅳ alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR-mediated autophagy［J］.Mol Med Rep，2021，23（6）：437.

ZHU K N，TIAN S S，WANG H，et al.Study on effect of gypenosides on insulin sensitivity of rats with diabetes mellitus via regulating NF-κB signaling pathway［J］.Chin J Chin Mat Med，2021，46（17）：4488-4496.

FAN X，ZHANG C，NIU S，et al.Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation［J］.Eur J Pharmacol，2019，854（4）：247-255.

YUNG J H M，GIACCA A.Role of c-Jun N-terminal kinase （JNK） in obesity and type 2 diabetes［J］.Cells，2020，9（3）：706.

LIM A K，NIKOLIC-PATERSON D J，MA F Y，et al.Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice［J］.Diabetologia，2009，52（2）：347-58.

XU H，WANG Q，SUN Q，et al.In type 2 diabetes induced by cigarette smoking，activation of p38 MAPK is involved in pancreatic β-cell apoptosis［J］.Environ Sci Pollut Res Int，2018，25（10）：9817-9827.

SHI Y，WAN X，SHAO N，et al.Protective and anti-angiopathy effects of ginsenoside Re against diabetes mellitus via the activation of p38 MAPK，ERK1/2 and JNK signaling［J］.Mol Med Rep，2016，14（5）：4849-4856.

KIM Y J，PARK S M，JUNG H S，et al.Ginsenoside Rg3 prevents INS-1 cell death from intermittent high glucose stress［J］.Islets，2016，8（3）：57-64.

JIANG B，YANG Y，JIN H，et al.Astragaloside Ⅳ attenuates lipolysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes［J］.Phytother Res，2008，22（11）：1434-1439.

曹萌.人参皂苷Rb1通过抑制JNK信号通路改善糖尿病大鼠肝脏糖脂代谢异常［J］.中国免疫学杂志，2018，34（4）：531-536，548.

YARIBEYGI H，SATHYAPALAN T，ATKIN S L，et al.Molecular mechanisms linking oxidative stress and diabetes mellitus［J］.Oxid Med Cell Longev，2020，doi：10.1155/2020/8609213http://dx.doi.org/10.1155/2020/8609213.

ZHANG P，LI T，WU X，et al.Oxidative stress and diabetes： Antioxidative strategies［J］.Front Med，2020，14（5）：583-600.

程静，向明，吴涛，等.南苜蓿总皂苷对2型糖尿病大鼠糖脂代谢及胰岛细胞的作用［J］.中国医院药学杂志，2016，36（19）：1625-1628.

朱谋，巩晓晨，刘冬阳，等.人参皂苷Rb1对改善2型糖尿病大鼠糖脂代谢紊乱的作用［J］.食品工业科技，2022，43（3）：367-373.

JIANG S，XU L，XU Y，et al.Antidiabetic effect of Momordica charantia saponins in rats induced by high-fat diet combined with STZ［J］.Electron J Biotechnol，2020，43（8）：41-47.

李宝铜，夏星，钟斯然，等.罗汉果总皂苷对高糖高脂饲料联合链脲佐菌素致2型糖尿病大鼠的作用［J］.中国畜牧兽医，2020，47（12）：4148-4155.

韩冬.黄芪甲苷对实验性糖尿病大鼠降糖、调脂和抗氧化作用的研究［J］.现代中西医结合杂志，2016，25（4）：360-364.

WANG X Y，WANG Z Y，ZHU Y S，et al.Alleviation of cadmium-induced oxidative stress by trehalose via inhibiting the Nrf2-Keap1 signaling pathway in primary rat proximal tubular cells［J］.J Biochem Mol Toxicol，2018，32（1）：e22011-e22035.

BELLEZZA I，GIAMBANCO I，MINELLI A，et al.Nrf2-Keap1 signaling in oxidative and reductive stress［J］.Biochim Biophys Acta Mol Cell Res，2018，1865（5）：721-733.

GAO D，ZHAO M，QI X，et al.Hypoglycemic effect of Gynostemma pentaphyllum saponins by enhancing the Nrf2 signaling pathway in STZ-inducing diabetic rats［J］.Arch Pharm Res，2016，39（2）：221-230.

刘芬.知母皂苷通过Nrf2信号通路改善大鼠胰岛素抵抗的机制研究［D］.广州：广州中医药大学，2020.

LIU Y，DENG J，FAN D.G-Rh4 improves pancreatic β-cells dysfunction in vivo and in vitro by increased expression of Nrf2 and its target genes［J］.Food Chem Toxicol，2021，148（5）：111925-111942.

YANG G，WEI J，LIU P，et al.Role of the gut microbiota in type 2 diabetes and related diseases［J］.Metabolism，2021，117（9）：154712-154748.

GURUNG M，LI Z，YOU H，et al.Role of gut microbiota in type 2 diabetes pathophysiology［J］.EBioMedicine，2020，51（4）：102590-102623.

KARLSSON F，TREMAROLI V，NIELSEN J，et al.Assessing the human gut microbiota in metabolic diseases［J］.Diabetes，2013，62（10）：3341-3349.

CHAI Y，LUO J，BAO Y.Effects of Polygonatum sibiricum saponin on hyperglycemia，gut microbiota composition and metabolic profiles in type 2 diabetes mice［J］.Biomed Pharmacother，2021，143（6）：112155-112171.

YAN H，LU J，WANG Y，GU W，et al.Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats［J］.Phytomedicine，2017，26（2）：45-54.

YANG S，HU T，LIU H，et al.Akebia saponin D ameliorates metabolic syndrome （MetS） via remodeling gut microbiota and attenuating intestinal barrier injury［J］.Biomed Pharmacother，2021，138（5）：111441-111452.

LIU J，LI Y，YANG P，et al.Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota［J］.Agric Food Chem，2017，65（42）：9237-9246.

NIU D，AN S，CHEN X，et al.Corni fructus as a natural resource can treat type 2 diabetes by regulating gut microbiota［J］.Am J Chin Med，2020，48（6）：1385-1407.

WEI Y，YANG H，ZHU C，et al.Hypoglycemic effect of ginsenoside Rg5 mediated partly by modulating gut microbiota dysbiosis in diabetic db/db mice［J］.Agric Food Chem，2020，68（18）：5107-5117.

XU J，LI T，XIA X，et al.Dietary ginsenoside T19 supplementation regulates glucose and lipid metabolism via AMPK and PI3K pathways and its effect on intestinal microbiota［J］.Agric Food Chem，2020，68（49）：14452-14462.

LI J，LI R，LI N，et al.Mechanism of antidiabetic and synergistic effects of ginseng polysaccharide and ginsenoside Rb1 on diabetic rat model［J］.Pharm Biomed Anal，2018，158（3）：451-460.

王新红，张迟，刘琳，等.皂苷类成分与肠道菌群相互作用研究进展［J］.中成药，2021，43（7）：1834-1839.

张圣洁，郭锦瑞，康安，等.肠道菌群对中药糖苷类成分脱糖基代谢的研究进展［J］.中国中药杂志，2013，38（10）：1459-1466.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Gegen Qinliantang and Its Modified Prescriptions Ameliorate Insulin Resistance in Type 2 Diabetes Mellitus： A Review

Pharmacological Effect of Phellodendri Chinensis Cortex and Active Components on Gout： A Review

Traditional Chinese Medicine Regulates Signaling Pathways to Treat Vitiligo：A Review

Qianjin Weijingtang in Treatment of Chronic Obstructive Pulmonary Disease： A Review

Anti-tumor Effect and Mechanism of Effective Components in Hedysari Radix： A Review

Related Author

LIU Yimin

JI Yanhua

CHEN Mengjie

YAN Xiaojun

LIU Hongning

ZENG Zhijun

LI Min

QUAN Yunyun

Related Institution

Research Center for Differentiation and Development of Traditional Chinese Medicine（TCM） Basic Theory， Jiangxi Province Key Laboratory of TCM Etiopathogenisis， Jiangxi University of Chinese Medicine

School of Pharmacy， Chengdu University of Traditional Chinese Medicine（TCM）

Sichuan Academy of Chinese Medicine Sciences， Sichuan Center for Translational Chinese Medicine， Key Laboratory of Biological Evaluation of Quality of TCM， State Administration of TCM， Sichuan Key Laboratory of Translational Chinese Medicine， Sichuan Engineering Technology Research Center of Genuine Regional Drug， Sichuan Provincial Engineering Research Center of Formation Principle and Quality Evaluation of Genuine Medicinal Materials

Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations， the "Double-First Class" Application Characteristic Discipline of Hunan Province （Pharmaceutical Science）， Changsha Medical University

Heilongjiang University of Chinese Medicine

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰